Oaktree Acquisition Corp. III Life Sciences Class A(OACC)
$10.73+0.01 (+0.09%)
OACC
Oaktree Acquisition Corp. III Life Sciences Class A financials statements
$10.73
At close:+0.01 (+0.09%)
Oaktree Acquisition Corp. III Life Sciences Class A (OACC) Ratios
0 Followers
Oaktree Acquisition Corp. III Life Sciences Class A Ratios
OACC's free cash flow for Q3 2026 was $-204.07K. For the 2026 fiscal year, OACC's free cash flow was increased by $0.00 and operating cash flow was $-204.07K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 |
|---|---|---|
| Liquidity Ratios | ||
| Current Ratio | 1.19 | 2.14 |
| Quick Ratio | 1.19 | 2.14 |
| Cash Ratio | 1.10 | 1.87 |
| Solvency Ratio | 0.88 | 0.00 |
| Operating Cash Flow Ratio | -0.32 | -0.00 |
| Short-Term Operating Cash Flow Coverage | -35.70 | -0.02 |
| Net Current Asset Value | $ -6.77M | $ -6.19M |
| Leverage Ratios | ||
| Debt-to-Assets Ratio | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.04 |
| Debt Service Coverage Ratio | -101.12 | -29.75 |
| Interest Coverage Ratio | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.19 | 3.82 |
| Profitability Margins | ||
| Gross Profit Margin | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% |
| EBT Per EBIT | -609.59% | -378.81% |
| Return on Assets (ROA) | 3.59% | 0.00% |
| Return on Equity (ROE) | 3.74% | 0.00% |
| Return on Capital Employed (ROCE) | -0.59% | -0.00% |
| Return on Invested Capital (ROIC) | -0.59% | -0.00% |
| Return on Tangible Assets | 3.59% | 0.00% |
| Earnings Yield | 3.59% | 0.00% |
| Efficiency Ratios | ||
| Receivables Turnover | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 |
| Cash Flow Ratios | ||
| Operating Cash Flow Per Share | -0.02 | -0.00 |
| Free Cash Flow Per Share | -0.02 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -59.67 |
| Capital Expenditure Coverage Ratio | 0.00 | -59.67 |
| Operating Cash Flow Coverage Ratio | -35.70 | -0.02 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 |
| Free Cash Flow Yield | -0.21% | -0.00% |
| Valuation Ratios | ||
| Price-to-Earnings (P/E) Ratio | 35.27 | 183.76 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.04 | 1.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -481.25 | -1367845.64 |
| Price-to-Operating Cash Flow Ratio | -481.25 | -1367845.64 |
| Price-to-Earnings Growth (PEG) Ratio | 0.08 | 0.00 |
| Enterprise Value Multiple | -168.69 | -692.14 |
| Enterprise Value | 201.70M | 243.50M |
| EV to EBITDA | -168.69 | -692.14 |
| EV to Sales | 0.00 | 0.00 |
| EV to Free Cash Flow | -477.88 | -1360330.44 |
| EV to Operating Cash Flow | -477.88 | -1360330.44 |
| Tangible Book Value Per Share | 10.15 | 7.63 |
| Shareholders’ Equity Per Share | 10.15 | 7.63 |
| Tax and Other Ratios | ||
| Effective Tax Rate | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 |
| Net Income Per Share | 0.38 | 0.00 |
| Tax Burden | 1.00 | 1.00 |
| Interest Burden | -6.10 | -3.79 |
| Research & Development to Revenue | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 |
| Income Quality | -0.06 | -0.07 |
Currency in USD

